Daicel Valuation
| DACHFDelisted Stock | USD 8.52 0.00 0.00% |
At this time, the firm appears to be overvalued. Daicel shows a prevailing Real Value of $7.2 per share. The current price of the firm is $8.52. Our model computes the value of Daicel from reviewing the firm fundamentals such as Profit Margin of 0.07 %, shares outstanding of 291.55 M, and Current Valuation of 3.6 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Daicel's price fluctuation is very steady at this time. Calculation of the real value of Daicel is based on 3 months time horizon. Increasing Daicel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Daicel pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Daicel. Since Daicel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Daicel Pink Sheet. However, Daicel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.52 | Real 7.2 | Hype 8.52 | Naive 8.42 |
The real value of Daicel Pink Sheet, also known as its intrinsic value, is the underlying worth of Daicel Company, which is reflected in its stock price. It is based on Daicel's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Daicel's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Daicel helps investors to forecast how Daicel pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Daicel more accurately as focusing exclusively on Daicel's fundamentals will not take into account other important factors: Daicel Total Value Analysis
Daicel is currently forecasted to have takeover price of 3.6 B with market capitalization of 1.78 B, debt of 236.03 B, and cash on hands of 90.53 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Daicel fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.6 B | 1.78 B | 236.03 B | 90.53 B |
Daicel Investor Information
About 57.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Daicel last dividend was issued on the 30th of March 2023. Daicel is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Daicel Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Daicel has an asset utilization ratio of 66.96 percent. This implies that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Daicel is more efficient with each dollar of assets it utilizes for everyday operations.Daicel Ownership Allocation
Daicel holds a total of 291.55 Million outstanding shares. Over half of Daicel's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Daicel Profitability Analysis
The company reported the revenue of 467.94 B. Net Income was 31.25 B with profit before overhead, payroll, taxes, and interest of 138.61 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Daicel's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Daicel and how it compares across the competition.
About Daicel Valuation
The pink sheet valuation mechanism determines Daicel's current worth on a weekly basis. Our valuation model uses a comparative analysis of Daicel. We calculate exposure to Daicel's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Daicel's related companies.Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan. Daicel Chemical operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 11104 people.
8 Steps to conduct Daicel's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Daicel's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Daicel's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Daicel's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Daicel's revenue streams: Identify Daicel's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Daicel's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Daicel's growth potential: Evaluate Daicel's management, business model, and growth potential.
- Determine Daicel's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Daicel's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Daicel Growth Indicators
Investing in growth stocks can be very risky. If the company such as Daicel does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 295.7 M | |
| Quarterly Earnings Growth Y O Y | 4.172 | |
| Retained Earnings | 174.5 B |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Daicel Pink Sheet
If you are still planning to invest in Daicel check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Daicel's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |